Clinical and pathologic features of secondary acute promyelocytic leukemia

Amy S. Duffield, Joseph Aoki, Mark Levis, Kathleen Cowan, Christopher D. Gocke, Kathleen H. Burns, Michael J. Borowitz, Milena Vuica-Ross

Research output: Contribution to journalArticlepeer-review


Acute promyelocytic leukemia (APL) is a relatively common form of acute myeloid leukemia (AML) that has an excellent prognosis. In contrast, secondary acute myeloid leukemias, including therapy-related AML and AML with myelodysplasia-related changes, have a relatively poor prognosis. We identified 9 cases of APL at our institution in which there was a history of chemotherapy, radiotherapy, chronic immunosuppression, or antecedent myelodysplastic syndrome. The clinical and pathologic findings in these cases of secondary APL were compared with the clinical and pathologic findings in cases of de novo APL. We found that secondary and de novo APL had abnormal promyelocytes with similar morphologic and immunophenotypic features, comparable cytogenetic findings, comparable rates of FMS-like tyrosine kinase mutations, and similar rates of recurrent disease and death. These data suggest that secondary APL is similar to de novo APL and, thus, should be considered distinct from other secondary acute myeloid neoplasms. Copyright

Original languageEnglish (US)
Pages (from-to)395-402
Number of pages8
JournalAmerican journal of clinical pathology
Issue number3
StatePublished - Mar 2012


  • APL
  • Acute myeloid leukemia with myelodysplasia-related changes
  • Acute promyelocytic leukemia
  • Flow cytometry
  • Therapy-related acute myeloid leukemia
  • Therapy-related myeloid neoplasm

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'Clinical and pathologic features of secondary acute promyelocytic leukemia'. Together they form a unique fingerprint.

Cite this